Breaking News, Promotions & Moves

Avacta Names Karen Harrison COO for Therapeutics Division

Harrison has more than 30 years’ experience managing complex global B2C organizations.

Avacta Group plc, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, appointed of Karen Harrison as chief operating officer of its therapeutics division. Harrison will be responsible for supporting the research and development functions across Avacta’s therapeutics division, with a focus exclusively on creating maximum value for the group’s stakeholders. Latest clinical data for the company’s lead pre|CISION program, AVA6000, has demonstrated i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters